Pfizer and Genentech Duke it Out in Court over Herceptin Biosimilar Patents Post author:Sam Post published:November 21, 2017 Post category:BioPharma Genentech is claiming that Pfizer’s proposed biosimilar infringes 40 of its patents. Source: BioSpace You Might Also Like 19 Deaths, Serious Liver Injury Linked to Intercept Pharma's Ocaliva September 21, 2017 PENTAX Medical Launches New Slim Linear Ultrasound Endoscope August 8, 2017 Siemens Healthineers And HeartFlow Collaborate To Provide Solution That Has Potential To Lower Cardiac Care Costs March 16, 2017
Siemens Healthineers And HeartFlow Collaborate To Provide Solution That Has Potential To Lower Cardiac Care Costs March 16, 2017
